2023-20631: Horseracing Integrity and Safety Authority Anti-Doping and Medication Control Rule Modification
Public comment closed .
Get alerted when the next rule lands
New rules open for comment on their own schedule. Pick how you want to hear about them — we email you when one appears.
Publishing to members? Embed a live rule tracker on your own site — the proposed rules in your area and the comment deadlines closing on them, updating themselves. Free, one line of HTML.
Create a free account & build one →Summary
As required by the Horseracing Integrity and Safety Act of 2020, the Federal Trade Commission ("FTC" or "Commission") publishes a proposed rule modification related to the equine Anti- Doping and Medication Control Program of the Horseracing Integrity and Safety Authority ("HISA" or the "Authority"). Specifically, the proposed rule modification would designate iron dextran as a banned substance and thereby prohibit its use. This publication contains the Authority's proposed rule's text and explanation, and it seeks public comment on whether the Commission should approve the proposed rule.
The agency’s own summary, as published.
Don't miss the comment window
One Click Politics alerts you on every deadline, hearing, and rule change.
See all rules with comments due soon →